Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-029638
Filing Date
2024-12-17
Accepted
2024-12-17 17:27:49
Documents
1
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3104
  Complete submission text file 0001127602-24-029638.txt   4601
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Dickinson Andrew D (Reporting) CIK: 0001310204 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 241556833